Faegre Baker Daniels advised Endocyte, Inc. on its $86.2 million shelf-takedown offering of 20,535,714 shares of common stock, which includes full exercise of the underwriters’ greenshoe…
Endocyte’s $86.2 million shelf-takedown offering
Faegre Baker Daniels advised Endocyte, Inc. on its $86.2 million shelf-takedown offering of 20,535,714 shares of common stock, which includes full exercise of the underwriters’ greenshoe…